Stockfacts
Explore
Use Cases
Docs
Pricing
English
Log in
Sign up free
Overview
Financials
Trends
Transcripts
Options
Shorts
Institutions
Insiders
Corporate Actions
SEC Filings
EDIT
Editas Medicine, Inc.
CIK 0001650664 · Nasdaq
Nasdaq
Health Care
Biological Products, (No Diagnostic Substances)
$3.11
↑ 0.17 (5.78%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read:
Bullish
Overall score · based on 4/4 lenses
Fundamentals
Ownership
Technicals
Options
Bullish: Ownership, Technicals
Key stats
Market Cap
$477.63M
P/E Ratio
-6.46
EPS
-1.80
Dividend Yield
Not covered
52W Position
50%
Beta
2.12
Valuation multiples
Fwd P/E
Not covered
PEG
0.00
P/B
4.54
P/S
10.16
EV/Revenue
7.48
ROE
-70.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).
Price · 1Y
251 trading days
End-of-day close, not real-time intraday
52-Week Range
Position 50%
$1.66
$4.54
Latest Financials
2025-12-31 FY
Revenue
$40.52M
Net Income
-$160.06M
Total Assets
$186.53M
Free Cash Flow
-$165.85M
Recent news